CURRENT ISSUES IN THE DEVELOPMENT OF NEUROPROTECTIVE THERAPY IN ISCHEMIC STROKE
DOI:
https://doi.org/10.17605/OSF.IO/P785AKeywords:
Stroke,, neuroprotectors,, cytokinesAbstract
The article demonstrates the world experience in the use of metabolic therapy in the treatment of ischemic stroke. The question is resonant. The feasibility of prescribing metabolic drugs is not completely clear, the effectiveness has not been definitively proven, despite numerous studies that only show trends. The article presents a review of the most popular drugs from different pharmacological groups with metabolic action that affect different links of the ischemic cascade.